Selected research
Industry Research
E-Prescribing (eRx) Platform Industry Research Report 2026
Market perspective
The global E-Prescribing (eRx) Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the E-Prescribing (eRx) Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the E-Prescribing (eRx) Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the E-Prescribing (eRx) Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of E-Prescribing (eRx) Platform include MediRecords, RxSure, DrFirst, DoseSpot, Veradigm (Allscripts), Practice Fusion, Chetu, Ensora (formerly NewCrop) and Qualifacts, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global E-Prescribing (eRx) Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to E-Prescribing (eRx) Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
E-Prescribing (eRx) Platform Market by Company
MediRecords
RxSure
DrFirst
DoseSpot
Veradigm (Allscripts)
Practice Fusion
Chetu
Ensora (formerly NewCrop)
Qualifacts
H2H Solutions
Oracle Health
Optum
DAW (ScriptSure)
Tebra
EverHealth (DrChrono)
Surescripts
RXNT
iPrescribe
E-Prescribing (eRx) Platform Segment by Type
Cloud-based
On-premise
E-Prescribing (eRx) Platform Segment by Application
Physician Practice eRx
Health System eRx
Dental and Behavioral Health eRx
Telehealth eRx
Long-term Care eRx
E-Prescribing (eRx) Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E-Prescribing (eRx) Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of E-Prescribing (eRx) Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E-Prescribing (eRx) Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of E-Prescribing (eRx) Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premise
Applications
- Physician Practice eRx
- Health System eRx
- Dental and Behavioral Health eRx
- Telehealth eRx
- Long-term Care eRx
Companies covered
- MediRecords
- RxSure
- DrFirst
- DoseSpot
- Veradigm (Allscripts)
- Practice Fusion
- Chetu
- Ensora (formerly NewCrop)
- Qualifacts
- H2H Solutions
- Oracle Health
- Optum
- DAW (ScriptSure)
- Tebra
- EverHealth (DrChrono)
- Surescripts
- RXNT
- iPrescribe
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 E-Prescribing (eRx) Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-premise
- 2.3 E-Prescribing (eRx) Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Physician Practice eRx
- 2.3.3 Health System eRx
- 2.3.4 Dental and Behavioral Health eRx
- 2.3.5 Telehealth eRx
- 2.3.6 Long-term Care eRx
- 2.4 Assumptions and Limitations
3 E-Prescribing (eRx) Platform Breakdown Data by Type
- 3.1 Global E-Prescribing (eRx) Platform Historic Market Size by Type (2021-2026)
- 3.2 Global E-Prescribing (eRx) Platform Forecasted Market Size by Type (2027-2032)
4 E-Prescribing (eRx) Platform Breakdown Data by Application
- 4.1 Global E-Prescribing (eRx) Platform Historic Market Size by Application (2021-2026)
- 4.2 Global E-Prescribing (eRx) Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global E-Prescribing (eRx) Platform Market Perspective (2021-2032)
- 5.2 Global E-Prescribing (eRx) Platform Growth Trends by Region
- 5.2.1 Global E-Prescribing (eRx) Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 E-Prescribing (eRx) Platform Historic Market Size by Region (2021-2026)
- 5.2.3 E-Prescribing (eRx) Platform Forecasted Market Size by Region (2027-2032)
- 5.3 E-Prescribing (eRx) Platform Market Dynamics
- 5.3.1 E-Prescribing (eRx) Platform Industry Trends
- 5.3.2 E-Prescribing (eRx) Platform Market Drivers
- 5.3.3 E-Prescribing (eRx) Platform Market Challenges
- 5.3.4 E-Prescribing (eRx) Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top E-Prescribing (eRx) Platform Players by Revenue
- 6.1.1 Global Top E-Prescribing (eRx) Platform Players by Revenue (2021-2026)
- 6.1.2 Global E-Prescribing (eRx) Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global E-Prescribing (eRx) Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of E-Prescribing (eRx) Platform Head Office and Area Served
- 6.4 Global E-Prescribing (eRx) Platform Players, Product Type & Application
- 6.5 Global E-Prescribing (eRx) Platform Manufacturers Established Date
- 6.6 Global E-Prescribing (eRx) Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America E-Prescribing (eRx) Platform Market Size (2021-2032)
- 7.2 North America E-Prescribing (eRx) Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America E-Prescribing (eRx) Platform Market Size by Country (2021-2026)
- 7.4 North America E-Prescribing (eRx) Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe E-Prescribing (eRx) Platform Market Size (2021-2032)
- 8.2 Europe E-Prescribing (eRx) Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe E-Prescribing (eRx) Platform Market Size by Country (2021-2026)
- 8.4 Europe E-Prescribing (eRx) Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific E-Prescribing (eRx) Platform Market Size (2021-2032)
- 9.2 Asia-Pacific E-Prescribing (eRx) Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific E-Prescribing (eRx) Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific E-Prescribing (eRx) Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America E-Prescribing (eRx) Platform Market Size (2021-2032)
- 10.2 South America E-Prescribing (eRx) Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America E-Prescribing (eRx) Platform Market Size by Country (2021-2026)
- 10.4 South America E-Prescribing (eRx) Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa E-Prescribing (eRx) Platform Market Size (2021-2032)
- 11.2 Middle East & Africa E-Prescribing (eRx) Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa E-Prescribing (eRx) Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa E-Prescribing (eRx) Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 MediRecords
- 12.1.1 MediRecords Company Information
- 12.1.2 MediRecords Business Overview
- 12.1.3 MediRecords Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.1.4 MediRecords E-Prescribing (eRx) Platform Product Portfolio
- 12.1.5 MediRecords Recent Developments
- 12.2 RxSure
- 12.2.1 RxSure Company Information
- 12.2.2 RxSure Business Overview
- 12.2.3 RxSure Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.2.4 RxSure E-Prescribing (eRx) Platform Product Portfolio
- 12.2.5 RxSure Recent Developments
- 12.3 DrFirst
- 12.3.1 DrFirst Company Information
- 12.3.2 DrFirst Business Overview
- 12.3.3 DrFirst Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.3.4 DrFirst E-Prescribing (eRx) Platform Product Portfolio
- 12.3.5 DrFirst Recent Developments
- 12.4 DoseSpot
- 12.4.1 DoseSpot Company Information
- 12.4.2 DoseSpot Business Overview
- 12.4.3 DoseSpot Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.4.4 DoseSpot E-Prescribing (eRx) Platform Product Portfolio
- 12.4.5 DoseSpot Recent Developments
- 12.5 Veradigm (Allscripts)
- 12.5.1 Veradigm (Allscripts) Company Information
- 12.5.2 Veradigm (Allscripts) Business Overview
- 12.5.3 Veradigm (Allscripts) Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.5.4 Veradigm (Allscripts) E-Prescribing (eRx) Platform Product Portfolio
- 12.5.5 Veradigm (Allscripts) Recent Developments
- 12.6 Practice Fusion
- 12.6.1 Practice Fusion Company Information
- 12.6.2 Practice Fusion Business Overview
- 12.6.3 Practice Fusion Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.6.4 Practice Fusion E-Prescribing (eRx) Platform Product Portfolio
- 12.6.5 Practice Fusion Recent Developments
- 12.7 Chetu
- 12.7.1 Chetu Company Information
- 12.7.2 Chetu Business Overview
- 12.7.3 Chetu Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.7.4 Chetu E-Prescribing (eRx) Platform Product Portfolio
- 12.7.5 Chetu Recent Developments
- 12.8 Ensora (formerly NewCrop)
- 12.8.1 Ensora (formerly NewCrop) Company Information
- 12.8.2 Ensora (formerly NewCrop) Business Overview
- 12.8.3 Ensora (formerly NewCrop) Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.8.4 Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Product Portfolio
- 12.8.5 Ensora (formerly NewCrop) Recent Developments
- 12.9 Qualifacts
- 12.9.1 Qualifacts Company Information
- 12.9.2 Qualifacts Business Overview
- 12.9.3 Qualifacts Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.9.4 Qualifacts E-Prescribing (eRx) Platform Product Portfolio
- 12.9.5 Qualifacts Recent Developments
- 12.10 H2H Solutions
- 12.10.1 H2H Solutions Company Information
- 12.10.2 H2H Solutions Business Overview
- 12.10.3 H2H Solutions Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.10.4 H2H Solutions E-Prescribing (eRx) Platform Product Portfolio
- 12.10.5 H2H Solutions Recent Developments
- 12.11 Oracle Health
- 12.11.1 Oracle Health Company Information
- 12.11.2 Oracle Health Business Overview
- 12.11.3 Oracle Health Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.11.4 Oracle Health E-Prescribing (eRx) Platform Product Portfolio
- 12.11.5 Oracle Health Recent Developments
- 12.12 Optum
- 12.12.1 Optum Company Information
- 12.12.2 Optum Business Overview
- 12.12.3 Optum Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.12.4 Optum E-Prescribing (eRx) Platform Product Portfolio
- 12.12.5 Optum Recent Developments
- 12.13 DAW (ScriptSure)
- 12.13.1 DAW (ScriptSure) Company Information
- 12.13.2 DAW (ScriptSure) Business Overview
- 12.13.3 DAW (ScriptSure) Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.13.4 DAW (ScriptSure) E-Prescribing (eRx) Platform Product Portfolio
- 12.13.5 DAW (ScriptSure) Recent Developments
- 12.14 Tebra
- 12.14.1 Tebra Company Information
- 12.14.2 Tebra Business Overview
- 12.14.3 Tebra Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.14.4 Tebra E-Prescribing (eRx) Platform Product Portfolio
- 12.14.5 Tebra Recent Developments
- 12.15 EverHealth (DrChrono)
- 12.15.1 EverHealth (DrChrono) Company Information
- 12.15.2 EverHealth (DrChrono) Business Overview
- 12.15.3 EverHealth (DrChrono) Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.15.4 EverHealth (DrChrono) E-Prescribing (eRx) Platform Product Portfolio
- 12.15.5 EverHealth (DrChrono) Recent Developments
- 12.16 Surescripts
- 12.16.1 Surescripts Company Information
- 12.16.2 Surescripts Business Overview
- 12.16.3 Surescripts Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.16.4 Surescripts E-Prescribing (eRx) Platform Product Portfolio
- 12.16.5 Surescripts Recent Developments
- 12.17 RXNT
- 12.17.1 RXNT Company Information
- 12.17.2 RXNT Business Overview
- 12.17.3 RXNT Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.17.4 RXNT E-Prescribing (eRx) Platform Product Portfolio
- 12.17.5 RXNT Recent Developments
- 12.18 iPrescribe
- 12.18.1 iPrescribe Company Information
- 12.18.2 iPrescribe Business Overview
- 12.18.3 iPrescribe Revenue in E-Prescribing (eRx) Platform Business (2021-2026)
- 12.18.4 iPrescribe E-Prescribing (eRx) Platform Product Portfolio
- 12.18.5 iPrescribe Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst